More on BCTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (1/15/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BriaCell Therapeutics (NQ:BCTX)
Delayed: 3.26 -0.05 (1.51%)
Prev. Close $3.31  
Open$3.37 
52 Wk High$ 
52 Wk Low$ 
Day High$3.37 
Day Low$3.24 
P/E N/A  
EPS$ 
Volume102,206 

Friends, Peers and Foes (?): BCT, BCTXW, BCTXZ BCTXL (more...)

Jun 3, 2026 06:04 AM Form 8-K BriaCell Therapeutics For: May 31
Jun 2, 2026 08:01 AM Form 424B5 BriaCell Therapeutics
May 31, 2026 07:59 PM BriaCell Therapeutics Announces Pricing of Offering
May 15, 2026 07:31 AM BriaCell develops ovarian cancer immunotherapy candidate
May 15, 2026 07:30 AM BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™
May 14, 2026 07:31 AM BriaCell completes manufacturing of prostate cancer therapy supplies
May 14, 2026 07:30 AM BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer
May 13, 2026 07:30 AM BriaCell adds Penn Medicine cancer center to phase 3 breast cancer trial
May 13, 2026 07:30 AM BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
May 12, 2026 07:30 AM BriaCell enrolls over 230 patients in phase 3 breast cancer study
View All Articles

Entities mentioned with BCTX

View All Entities